David Millar calls for Bradley Wiggins's TUE medication to be banned
David Millar explains his experience with the triamcinolone drug that was prescribed to Bradley Wiggins, describing it as "powerful" and "destructive"
- (opens in new tab)
- (opens in new tab)
- (opens in new tab)
- Sign up to our newsletter Newsletter

David Millar is calling on the World Anti-Doping Agency (WADA) to completely ban the corticosteroid used by Sir Bradley Wiggins during his time with Team Sky, calling the drug "powerful" and "destructive".
In a data leak last week it was revealed that Wiggins received six therapeutic use exemptions (TUEs) during his career, three for triamcinolone, which was used to treat a pollen allergy.
Wiggins's use of the drug was sanctioned by the UCI ahead of the 2011 and 2012 Tour de France and the 2013 Giro d'Italia. There is no suggestion of any wrongdoing by Wiggins.
In an interview with the Telegraph's Tom Cary, Millar described his experience of the drug, saying Kenacort – a trade name for triamcinolone - "put you on this weird high”, having used it himself in the past.
The former Garmin professional, who served a two year ban for drug use in his early career and is now an active anti-doping campaigner, did not comment on the Wiggins case, but shared his experience of Kenacort.
“You would do all the training but my weight would stick,” he said, referencing his own use of EPO and testosterone patches. “But if I took Kenacort, 1.5-2kgs would drop off in like a week. And not only would the weight drop off I would feel stronger.
“If you are non-asthmatic and you take Ventolin it’s not going to give you any advantage. But if you take Kenacort it’s not only going to make a sick person better, it’s going to make a sick person better than a healthy person. That’s a very grey area.
“I’m sure there are other forms of cortisone that could be used for allergies which aren’t so potent or performance-enhancing.” He added: “We [athletes] shouldn’t have to face this. If it’s that strong we shouldn’t be allowed to take it unless there is a serious issue.
"And if we’re suffering from that serious an issue, we shouldn’t be racing. I don’t know how a doctor could prescribe it [before a race]. I can’t fathom it.”
In a statement released on Wiggins's behalf following the data leak, it was insisted there was "nothing new" in the revelations, which have left the 2012 Tour champion under fire due to his his previous statements regarding Team Sky's 'no-needle' policy.
“The triamcinolone injection that is referred to in the WADA leaks is an intramuscular treatment for asthma and is fully approved by the sport’s governing bodies," the statement read.
Thank you for reading 10 articles this month* Join now for unlimited access
Enjoy your first month for just £1 / $1 / €1
*Read 5 free articles per month without a subscription
Join now for unlimited access
Try first month for just £1 / $1 / €1
Stuart Clarke is a News Associates trained journalist who has worked for the likes of the British Olympic Associate, British Rowing and the England and Wales Cricket Board, and of course Cycling Weekly. His work at Cycling Weekly has focused upon professional racing, following the World Tour races and its characters.
-
-
20 year-old sprints to clean sweep at British Track Champs
Emma Finucane wins two titles on the closing day of the championships
By Vern Pitt • Published
-
Marius Mayrhofer pulls off surprise win at Cadel Evans Great Ocean Road Race
DSM rider breaks down with emotion after he crosses the finish line
By Stephen Puddicombe • Published
-
Global backers in talks over new British WorldTour team
Former management of Ribble Weldtite courting interest in new project
By Tom Thewlis • Published
-
'I remember the crowds more than anything': Tom Pidcock recalls his Alpe d'Huez Tour de France stage win
Our male rider of the year, Tom Pidcock, talks us through the highs and lows of his 2022 campaign
By Tom Thewlis • Published
-
Leo Hayter, Cycling Weekly's rising star of 2022, talks through his season in the spotlight
We caught up with the winner of the "Baby Giro" to hear all about the win in Italy and his dream move to Ineos Grenadiers
By Tom Thewlis • Published
-
Ineos Grenadiers release 'visibly fast' 2023 jersey
Navy is replaced with red as British team changes its look
By Adam Becket • Published
-
Where next for Mark Cavendish after B & B Hotels-KTM's collapse?
We look at where the ‘Manx Missile’ could find himself next after the collapse of B & B Hotels-KTM
By Tom Thewlis • Published
-
‘It’s a good thing and shows progression of the sport’ - Ben Swift hails changes at British Cycling academy
Ineos Grenadier says putting academy riders in with development teams will encourage development of many skills
By Tom Thewlis • Published
-
'I know I can do it so I need to make that next level': Ben Turner signs Ineos Grenadiers contract extension
The Classics and another Grand Tour are on the agenda for Doncaster's Big Ben
By Chris Marshall-Bell • Published
-
Tom Pidcock unsure whether he will defend cyclocross world title in 2023
“I don’t know yet, crossing in the winter and being good in the classics is a difficult combination” Pidcock said
By Tom Thewlis • Published